ERBB2 and breast carcinoma: A study comparing triple-negative human breast cancer (oestrogen− progesterone−, HER-2−) with luminal HER-2+ breast cancer found excessive NET formation in the case of triple-negative human breast cancer that correlated with the spread of metastases [103].